MedPath

Comparing the therapeutic effects of two methods of injectable iron and oral iron on quality of life, sleep quality and breastfeeding self-efficacy in women with iron deficiency/ iron deficiency anemia in the postpartum period (postpartum)

Phase 3
Conditions
Postpartum Anemia.
Anemia of the puerperium
O90.81
Registration Number
IRCT20231023059817N4
Lead Sponsor
Zistaroo Danesh Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
170
Inclusion Criteria

Mothers who have hemoglobin between 9 and 10.5 g/dl after giving birth.
Having informed consent

Exclusion Criteria

History of anemia due to reasons other than iron deficiency and blood loss during pregnancy or being pregnant
The presence of more bleeding than usual postpartum (after the first 24 hours, more than menses or passing a large clot)
Severe active infection
Having a history of allergy to injectable iron
The presence of systemic disease in the mother (patients who received erythropoiesis stimulator (erythropoietin) during the last 3 months, patients who received myelosuppressive treatment and blood or blood products during delivery, patients with asthma under treatment, patients with hepatitis, Patients with HIV, patients with blood problems other than iron deficiency, patients with IBD, patients with CKD (eGFR<60)
Having a history of sleep disorder or depression and mothers who need to receive antidepressants.
Mothers who have suffered the death of a fetus or baby
Taking PPI, H2 blocker and antihistamine

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath